← Eichor
Study identifier: NCT05913713 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

HIIT Following Breast Cancer Chemotherapy

Condition: Breast Cancer  ·  Sponsor: University of Florida

PhaseNA
Planned participants158
Who can joinFemale, 18 Years to 85 Years
Healthy volunteersNo

About this study

Chemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately 95%. However, breast cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect and durability of a novel high-intensity interval training compared to moderate-intensity continuous training on cardiovascular rehabilitation in breast cancer survivors.

This description comes directly from the study's public registry record.

Talk to the study team

Demetra Christou, PhD  ·  352-294-1746  ·  ddchristou@ufl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Integrative Cardiovascular Physiology Laboratory, University of FloridaGainesville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05913713